i 1.00 Hours

Course Overview

The use of benzodiazepines as sedatives and hypnotic agents dates back decades. Benzodiazepines have become one of the most popular and widely prescribed medication classes due to their versatility in managing various diseases. Benzodiazepines are approved for use in patients diagnosed with insomnia, anxiety, seizures, alcohol withdrawal, and muscle spasms. They may be used in combination with other medications for light sedation and anesthesia. This class of medications is also used off-label for drug-induced movement disorders, agitation, intractable hiccups, nausea, and vomiting. When used for a limited amount of time with appropriate dosing, benzodiazepines are considered safe and effective medications. However, they also have become one of the most highly misused and abused prescribed medications. Benzodiazepines are commonly associated with substance abuse and overdose, especially when used in combination with other sedatives and opioids.

About the Course Author

Nicole Schroeder, PharmD, BCPS, BCCCP, is an assistant professor of clinical pharmacy for the Philadelphia College of Pharmacy at the University of the Sciences who specializes in critical care. Nicole M. Schroeder, PharmD, BCPS, BCCCP has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.

Get started now and your first course is free!

Become a member today and enjoy instant savings on all courses

Accreditation Information

Certificates provided by accrediting body (1 Match)

  • Florida Board of Pharmacy


    Florida Board of Pharmacy (CEBroker Provider #50-290)

    This module is approved for 1.0 contact hours.

Course Details
  • Course Code:

  • Hours:

  • Type:

    Online Course
  • Release Date:

  • Expiration Date:

  • Learning Objectives:

    Develop treatment and management plans for benzodiazepine overdose; Identify prevention methods to decrease the risk of overdose from benzodiazepines; Summarize the pharmacologic mechanism of action and therapeutic uses of benzodiazepines
  • Target Audience:

    The target audience for this course is: Pharmacists; in the following settings: Acute Care Facility.
  • Course Delivery Method and Format:

    Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
    Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
    If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
    All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
    Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
    All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
    To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
  • Accommodations:

    If you require special accommodations to complete this module, please contact Relias Customer Support here.
  • Disclosures:

    Expert Reviewers, Instructors, and Staff Writers disclosures will be listed above after the individuals' biographical paragraph. All other members involved within the planning of this educational activity have declared no conflict of interest exists when planning and developing this course.